Targeting proteinuria as a valid surrogate for individualized kidney protective therapy

被引：14

作者：

de Zeeuw, Dick ^{[1
]}

机构：

[1] Univ Groningen, Med Ctr, Dept Clin Pharmacol, Groningen, Netherlands

来源：

AMERICAN JOURNAL OF KIDNEY DISEASES | 2008年 / 51卷 / 05期

关键词：

D O I：

10.1053/j.ajkd.2008.03.013

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：713 / 716

页数：4

共 31 条

[1] Antiproteinuric effect of oral paricalcitol in chronic kidney disease [J].

Agarwal, R ;

Acharya, M ;

Tian, J ;

Hippensteel, RL ;

Melnick, JZ ;

Qiu, P ;

Williams, L ;

Batlle, D .

KIDNEY INTERNATIONAL, 2005, 68 (06) :2823-2828

[2] Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis - A randomized controlled trial [J].

Agodoa, LY ;

Appel, L ;

Bakris, GL ;

Beck, G ;

Bourgoignie, J ;

Briggs, JP ;

Charleston, J ;

Cheek, D ;

Cleveland, W ;

Douglas, JG ;

Douglas, M ;

Dowie, D ;

Faulkner, M ;

Gabriel, A ;

Gassman, J ;

Greene, T ;

Hall, Y ;

Hebert, L ;

Hiremath, L ;

Jamerson, K ;

Johnson, CJ ;

Kopple, J ;

Kusek, J ;

Lash, J ;

Lea, J ;

Lewis, JB ;

Lipkowitz, M ;

Massry, S ;

Middleton, J ;

Miller, ER ;

Norris, K ;

O'Connor, D ;

Ojo, A ;

Phillips, RA ;

Pogue, V ;

Rahman, M ;

Randall, OS ;

Rostand, S ;

Schulman, G ;

Smith, W ;

Thornley-Brown, D ;

Tisher, CC ;

Toto, RD ;

Wright, JT ;

Xu, SC .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (21) :2719-2728

[3]

APPERLOO AJ, 1994, KIDNEY INT, V45, P174

[4] Proteinuria reduction and progression to renal failure in patients with type 2 diabetes mellitus and overt nephropathy [J].

Atkins, RC ;

Briganti, EM ;

Lewis, JB ;

Hunsicker, LG ;

Braden, G ;

de Crespigny, PJC ;

DeFerrari, G ;

Drury, P ;

Locatelli, F ;

Wiegmann, TB ;

Lewis, EJ .

AMERICAN JOURNAL OF KIDNEY DISEASES, 2005, 45 (02) :281-287

[5]

BOS H, 2000, KIDNEY INT S, V75, P32

[6] Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy [J].

Brenner, BM ;

Cooper, ME ;

de Zeeuw, D ;

Keane, WF ;

Mitch, WE ;

Parving, HH ;

Remuzzi, G ;

Snapinn, SM ;

Zhang, ZX ;

Shahinfar, S .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (12) :861-869

[7] The blunting of the antiproteinuric efficacy of ACE inhibition by high sodium intake can be restored by hydrochlorothiazide [J].

Buter, H ;

Hemmelder, MH ;

Navis, G ;

de Jong, PE ;

de Zeeuw, D .

NEPHROLOGY DIALYSIS TRANSPLANTATION, 1998, 13 (07) :1682-1685

[8] Renoprotective therapy: titration against urinary protein excretion [J].

De Jong, PE ;

Navis, G ;

de Zeeuw, D .

LANCET, 1999, 354 (9176) :352-353

[9] Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: Lessons from RENAAL [J].

de Zeeuw, D ;

Remuzzi, G ;

Parving, HH ;

Keane, WF ;

Zhang, ZX ;

Shahinfar, S ;

Snapinn, S ;

Cooper, MF ;

Mitch, WE ;

Brenner, BM .

KIDNEY INTERNATIONAL, 2004, 65 (06) :2309-2320

[10] Albuminuria is a target for renoprotective therapy independent from blood pressure in patients with type 2 diabetic nephropathy:: Post hoc analysis from the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial [J].

Eijkelkamp, Wouter B. A. ;

Zhang, Zhongxin ;

Remuzzi, Giuseppe ;

Parving, Hans-Henrik ;

Cooper, Mark E. ;

Keane, William F. ;

Shahinfar, Shahnaz ;

Gleim, Gilbert W. ;

Weir, Matthew R. ;

Brenner, Barry M. ;

de Zeeuw, Dick .

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2007, 18 (05) :1540-1546

← 1 2 3 4 →